Global Peptic Ulcer Drugs Market 2023-2033: Increasing NSAID Consumption Boding Well for Growth of the Market | PMR

The peptic ulcer drugs market refers to the segment of the pharmaceutical industry that deals with the production and sale of drugs used to treat peptic ulcers, which are painful sores that occur in the lining of the stomach, esophagus, or duodenum (the first part of the small intestine).

The peptic ulcer drugs market has been growing in recent years, driven by the increasing prevalence of peptic ulcers, the growing aging population, and the increasing demand for effective treatments. In addition, advancements in technology and the development of new and innovative treatments are also driving growth in the market.

Request For Free Sample Report of "Peptic Ulcer Drugs Market"@ https://www.persistencemarketresearch.com/samples/3704

Surge in the consumption of NSAIDs due to growing prevalence of inflammatory diseases is the major factor driving the growth of the global peptic ulcer drugs market. Other trends driving growth include increasing adoption of peptic ulcer drugs over surgery, changes in disease management, prevalence of stress ulcers due to higher smoking rates, availability of affordable therapy due to improvements in the service sector, and increasing awareness toward disease management through government campaigns. However, chronic side-effects associated with the long-term use of peptic ulcer drugs is a factor hampering the growth of the global peptic ulcer drugs market to some extent.

As per PMR analysis, the global peptic ulcer drugs market is set for steady growth over the next ten years, to be valued at US$ 47.7 Bn by 2030-end.

Key Takeaways from Peptic Ulcer Drugs Market Study

By product, the proton pump inhibitors segment was the largest revenue generating segment in the historical years. However, revenue from the potassium-competitive acid blockers segment is expected to expand rapidly, owing to the introduction of new P-CAB drugs in the market.
Based on indication, the gastric ulcers segment is anticipated to expand at the highest CAGR of 3% over the forecast period.
On the basis of distribution channel, the hospital pharmacies segment led the global peptic ulcer drugs market, and is expected to remain the leading segment ahead too. Increasing hospitalization rates due to ulcer complications are expected to be the primary factor fuelling revenue growth of the segment over the forecast period.
North America holds the largest share in the global peptic ulcer drugs market, followed by Europe and East Asia.
Due to the worldwide COVID-19 outbreak, physician and hospital visits for non-essential treatment have reduced considerably, putting breaks on the progress of the peptic ulcer drugs market space.

"Increasing NSAID consumption is the major boosting factor for the growth of the global peptic ulcer drugs market," says a PMR analyst.

 Buy Full Report Now  @ https://www.persistencemarketresearch.com/checkout/3704

Peptic Ulcer Drugs Market: Competition Analysis

Key players operating in the global peptic ulcer drugs market are Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Pharmaceuticals Ltd. These companies are primarily focusing on strategies such as co-promotions and co-marketing of their brands to penetrate the fastest-growing emerging markets across the world.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the peptic ulcer drugs market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030. Research of this report has been done based segmentation into product, indication, and distribution channel, across seven key regions of the world.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/3704

Key Questions Answered in This Report.

What are the Roadblocks for Peptic Ulcer Drugs Market Suppliers?
What are the Key Opportunities for Peptic Ulcer Drugs Market Manufacturers?
How is Focus on Safety Influencing Peptic Ulcer Drugs Market Demand?
What is the Regulatory Impact on Global Sales of Peptic Ulcer Drugs Market?
Which Region Offers the Largest Opportunity for Sales of Peptic Ulcer Drugs Market?
Where Does the U.S. Stand in the Market for Peptic Ulcer Drugs Market?
What Is the Outlook for Peptic Ulcer Drugs Market Manufacturers in China?
Why is Germany a Lucrative Market for Peptic Ulcer Drugs Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Peptic Ulcer Drugs Market?
Why is There High Demand for Tires in Peptic Ulcer Drugs Market?
Why are Sales of Peptic Ulcer Drugs Market Surging?

For More Premium Insights, Check out the Link:

Europe Dental Imaging Equipment Market - https://www.prnewswire.com/news-releases/europe-dental-imaging-equipment-market-to-reach-a-valuation-of-us-1-3-bn-by-the-end-of-2032--persistence-market-research-301553679.html

Wound Antiseptics Market - https://www.prnewswire.com/news-releases/wound-antiseptics-market-projected-to-expand-at-a-steady-3-5-cagr-by-2022-2032--persistence-market-research-301547779.html

Demand For Lentiviral Vectors Market - https://www.prnewswire.com/news-releases/demand-for-lentiviral-vectors-market-is-estimated-to-surge-at-a-cagr-of-11-4--from-2022-to-2032--persistence-market-research-301547769.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.